| __timestamp | Arrowhead Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 241751000 |
| Thursday, January 1, 2015 | 57410147 | 322292000 |
| Friday, January 1, 2016 | 41454452 | 344320000 |
| Sunday, January 1, 2017 | 31690298 | 374644000 |
| Monday, January 1, 2018 | 52968505 | 414604000 |
| Tuesday, January 1, 2019 | 81048686 | 466000000 |
| Wednesday, January 1, 2020 | 128874979 | 535000000 |
| Friday, January 1, 2021 | 206342000 | 643000000 |
| Saturday, January 1, 2022 | 297307000 | 833000000 |
| Sunday, January 1, 2023 | 353188000 | 899625000 |
| Monday, January 1, 2024 | 505870000 |
Data in motion
In the ever-evolving world of pharmaceuticals, innovation is the lifeblood that drives progress. Over the past decade, Ionis Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc. have been at the forefront of this innovation, investing heavily in research and development (R&D). From 2014 to 2023, Ionis Pharmaceuticals consistently outpaced Arrowhead in R&D spending, with Ionis increasing its investment by approximately 272%, peaking in 2023. Meanwhile, Arrowhead's R&D expenses surged by an impressive 2,085% over the same period, reflecting its commitment to innovation. Notably, in 2024, Arrowhead's R&D spending reached a new high, while Ionis's data for that year remains unavailable. This trend underscores the dynamic nature of the pharmaceutical industry, where strategic investments in R&D are crucial for staying competitive and driving future growth.
Comparing Innovation Spending: Eli Lilly and Company and Ionis Pharmaceuticals, Inc.
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Ionis Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Summit Therapeutics Inc. vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Dr. Reddy's Laboratories Limited and Arrowhead Pharmaceuticals, Inc.
Research and Development Investment: Bio-Techne Corporation vs Ionis Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Arrowhead Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Pharming Group N.V. vs Arrowhead Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. vs CymaBay Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Ionis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated
R&D Spending Showdown: Perrigo Company plc vs Arrowhead Pharmaceuticals, Inc.
Comparing Innovation Spending: Arrowhead Pharmaceuticals, Inc. and Celldex Therapeutics, Inc.